PHARMACYTE BIOTECH INC (PMCB) Stock Income Statement
NASDAQ:PMCB - Nasdaq - US71715X2036 - Common Stock - Currency: USD
| TTM (2025-1-31) | 2024 (2024-4-30) | 2023 (2023-4-30) | 2022 (2022-4-30) | 2021 (2021-4-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 4.50M | 6.52M | 6.46M | 4.39M | 3.63M | |||
| Research and Development | 405.90K | 407.40K | 470.00K | 690.00K | 920.00K | |||
| Selling, General, and Administrative Expenses | 4.10M | 6.11M | 5.99M | 3.70M | 2.71M | |||
| Operating Income | -4.50M | -6.52M | -6.46M | -4.39M | -3.63M | |||
| Interest Income/Expense | 15.19M | 4.49M | 1.94M | 160.00K | 0.00 | |||
| Other Income/Expense | 13.14M | 5.94M | 200.00K | 0.00 | 0.00 | |||
| Non Recurring Items | N/A | -2.00M | N/A | 0.00 | 80.00K | |||
| Income Before Taxes | 20.25M | 333.80K | -4.32M | -4.24M | -3.55M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | 8.63M | -17.24M | -4.32M | -4.24M | -3.55M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.10 | -1.80 | -0.22 | -0.27 | -2.45 | |||
| Statistics | ||||||||
All data in USD